D. G. Grosset, E. G. Tyrrell, and K. A. Grosset, “Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases”., JRM, vol. 47, no. 2, pp. 183–186, Oct. 2014.